Exact Mass: 1134.5457906000001
Exact Mass Matches: 1134.5457906000001
Found 56 metabolites which its exact mass value is equals to given mass value 1134.5457906000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Azukisaponin VI
C54H86O25 (1134.5457906000001)
Azukisaponin VI is found in pulses. Azukisaponin VI is isolated from seeds of Vigna angularis (azuki bean). Isolated from seeds of Vigna angularis (azuki bean). Azukisaponin VI is found in pulses.
Calendasaponin C
C54H86O25 (1134.5457906000001)
Calendasaponin C is a constituent of flowers of Calendula officinalis (pot marigold). Constituent of flowers of Calendula officinalis (pot marigold)
Calendasaponin D
C54H86O25 (1134.5457906000001)
Calendasaponin D is a constituent of flowers of Calendula officinalis (pot marigold). Constituent of flowers of Calendula officinalis (pot marigold)
28-Glucosyl-30-methyl-3b,23-dihydroxy-12-oleanene-28,30-diate 3-[glucosyl-(1->3)-xylosyl-(1->2)-glucoside]
C54H86O25 (1134.5457906000001)
28-Glucosyl-30-methyl-3b,23-dihydroxy-12-oleanene-28,30-diate 3-[glucosyl-(1->3)-xylosyl-(1->2)-glucoside] is found in cereals and cereal products. 28-Glucosyl-30-methyl-3b,23-dihydroxy-12-oleanene-28,30-diate 3-[glucosyl-(1->3)-xylosyl-(1->2)-glucoside] is a constituent of Chenopodium quinoa (quinoa). Constituent of Chenopodium quinoa (quinoa). 28-Glucosyl-30-methyl-3b,23-dihydroxy-12-oleanene-28,30-diate 3-[glucosyl-(1->3)-xylosyl-(1->2)-glucoside] is found in cereals and cereal products.
CDP-DG(16:1(9Z)/LTE4)
CDP-DG(16:1(9Z)/LTE4) is an oxidized CDP-diacylglycerol (CDP-DG). Oxidized CDP-diacylglycerols are glycerophospholipids in which a cytidine diphosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized CDP-diacylglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. CDP-DG(16:1(9Z)/LTE4), in particular, consists of one chain of one 9Z-hexadecenoyl at the C-1 position and one chain of Leukotriene E4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized CDP-DGs can be synthesized via three different routes. In one route, the oxidized CDP-DG is synthetized de novo following the same mechanisms as for CDP-DGs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the CDP-DG backbone, mainly through the action of LOX (PMID: 33329396).
CDP-DG(LTE4/16:1(9Z))
CDP-DG(LTE4/16:1(9Z)) is an oxidized CDP-diacylglycerol (CDP-DG). Oxidized CDP-diacylglycerols are glycerophospholipids in which a cytidine diphosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized CDP-diacylglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. CDP-DG(LTE4/16:1(9Z)), in particular, consists of one chain of one Leukotriene E4 at the C-1 position and one chain of 9Z-hexadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized CDP-DGs can be synthesized via three different routes. In one route, the oxidized CDP-DG is synthetized de novo following the same mechanisms as for CDP-DGs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the CDP-DG backbone, mainly through the action of LOX (PMID: 33329396).
Azukisaponin VI
C54H86O25 (1134.5457906000001)
(3beta,4alpha)-3-hydroxyolean-12-en-23,28-dioic acid 28-{[O-beta-D-glucopyranosyl-(1->2)-O-beta-D-glucopyranosyl]-(1->6)-beta-D-glucopyranosyl}-(1->3)-beta-D-galactopyranosyl ester
C54H86O25 (1134.5457906000001)
15beta-hydroxylineolon 3-O-beta-D-glucopyranosyl-(1->4)-beta-D-thevetopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-cymaropyranoside
C55H90O24 (1134.5821740000001)
3beta-hydroxyolean-12-en-23,28-dioic acid 28-O-(beta-D-glucopyranosyl-(1-2)-beta-D-galactopyranosyl-(1-3))(beta-D-glucopyranosyl(1-6))beta-D-galactopyranoside|3beta-hydroxyolean-12-en-23,28-dioic acid 28-O-beta-D-galactopyranoside
C54H86O25 (1134.5457906000001)
(3beta)-3-O-{beta-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->4)]-beta-D-galactopyranosyl}gypsogenic acid|repensoside D
C54H86O25 (1134.5457906000001)
gypsogenicacid 28-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-[beta-D-glucopyranosyl-(1->3)]-beta-D-glucopyranosyl ester
C54H86O25 (1134.5457906000001)
12-O-deacylmetaplexigenin 3-O-beta-D-glucopyranosyl-(1->4)-beta-(6-deoxy-3-O-methyl)-D-allopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1-gt;4)-beta-D-cymaropyranosyl-(1->4)-beta-D-cymaropyranose|verticilloside I
C55H90O24 (1134.5821740000001)
28-O-[alpha-L-rhamnopyranosyl-(1?4)-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyl-(1?2)-beta-D-glucopyranosyl]medicagenic acid
C54H86O25 (1134.5457906000001)
3-O-[alpha-L-rhamnopyranosyl-(1 ? 2)-beta-D-glucopyranosyl-(1 ? 2)-beta-D-glucuronopyranosyl]-29-O-beta-D-glucopyranosyl-3beta,22beta,24,-trihydroxyolean-12-en-29-oic acid
C54H86O25 (1134.5457906000001)
3-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyloleane-12-en-23,28-dioic acid 28-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranoside|cowpeasaponin I
C54H86O25 (1134.5457906000001)
Quillaic acid 28-O-2)>2)-beta-D-galactopyranosyl(1-->6)>-beta-D-glucopyranoside|Quillaic acid 28-O-[beta-D-glucopyranosyl(1-->2)][beta-D-glucopyranosyl(1-->2)-beta-D-galactopyranosyl(1-->6)]-beta-D-glucopyranoside
C54H86O25 (1134.5457906000001)
3beta-hydroxyolean-12-en-23,28-dioic acid 28-O-(beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranosyl-(1-2))(beta-D-galactopyranosyl(1-6))beta-D-glucopyranoside|3beta-hydroxyolean-12-en-23,28-dioic acid 28-O-beta-D-glucopyranoside
C54H86O25 (1134.5457906000001)
28-O-(beta-D-glucopyranosyl)-3-O-{beta-D-glucopyranosyl-(1->2)[beta-D-glucopyranosyl-(1->4)]-beta-D-xylopyranosyl}phytolaccagenic acid|phytolaccasaponin N-5
C54H86O25 (1134.5457906000001)
3-O-[beta-D-galactopyranosyl-(1->2)-beta-D-glucuronopyranosyl]-28-O-[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl]hederagenin|giganteoside M
C54H86O25 (1134.5457906000001)
10-[(6-carboxy-4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-5-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-2-hydroxy-4,5,9,9,13,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosane-20-carboxylic acid
C54H86O25 (1134.5457906000001)
10-[6-Carboxy-4-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-5-hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2-hydroxy-4,5,9,9,13,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosane-20-carboxylic acid
C54H86O25 (1134.5457906000001)
Gypsosaponin C
C54H86O25 (1134.5457906000001)
A triterpenoid saponin with gypsogenic acid as the aglycone species. It is isolated from the roots of Gypsophila oldhamiana and exhibits inhibitory activity against pancreatic lipase.
2-methyl 4a-(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,4ar,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a-dicarboxylate
C54H86O25 (1134.5457906000001)
(2s,3s,4s,5r,6r)-6-{[(2s,3r,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-2-hydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-4-{[(2s,3r,4s,5s,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxyoxane-2-carboxylic acid
C54H86O25 (1134.5457906000001)
(3s,4s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-({[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-3,5-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}carbonyl)-3-hydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid
C54H86O25 (1134.5457906000001)
(2s,3s,4s,5r,6r)-6-{[(2s,3r,4r,4ar,6ar,6bs,8ar,12as,14ar,14br)-2-hydroxy-4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-8a-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-4-{[(2s,3r,4s,5s,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxyoxane-2-carboxylic acid
C54H86O25 (1134.5457906000001)
1-{3a,3b,10,11-tetrahydroxy-7-[(5-{[5-({5-[(3-hydroxy-4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-4-methoxy-6-methyloxan-2-yl}oxy)-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl)oxy]-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethanone
C55H90O24 (1134.5821740000001)
methyl 5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3,4-dihydroxy-6-{[9-hydroxy-4,11-bis(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamethyl-10-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}oxane-2-carboxylate
C55H90O24 (1134.5821740000001)
3,4-dihydroxy-6-{[4-(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-8a-({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid
C54H86O25 (1134.5457906000001)
(2r,3s,4r,5s)-3-{[(2s,3r,4s,5s,6s)-4-(acetyloxy)-3-hydroxy-6-methyl-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl (4ar,5r,6as,6br,8ar,10r,11s,12as,12br,14bs)-5,11-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
C54H86O25 (1134.5457906000001)
(2r,3s,4r,5r,6s)-2-{[(2s,3s,4r,5s,6s)-3-hydroxy-6-{[(1e,5e,10r)-11-{[(2r,3r,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-4-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,6,10-trimethylundeca-1,5-dien-1-yl]oxy}-2-(hydroxymethyl)-5-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-4-yl]oxy}-6-methyloxane-3,4,5-triol
2-methyl 4a-(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2s,4ar,6as,6br,8as,9r,10s,12ar,12br,14br)-10-{[(2s,3r,4s,5s)-4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-9-(hydroxymethyl)-2,6a,6b,9,12a-pentamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2,4a-dicarboxylate
C54H86O25 (1134.5457906000001)